● Recruiting

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

Condition: Primary Membranous Nephropathy · Sponsor: Vertex Pharmaceuticals Incorporated

PhasePhase 2/Phase 3

Planned participants176

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy, safety, and tolerability of povetacicept in participants with primary membranous nephropathy (pMN).

This description comes directly from the study's public registry record.

Talk to the study team

Medical Information · 001-617-341-6777 · medicalinfo@vrtx.com

Always discuss trial participation with your own doctor first.

Locations (108)

Renal Associates	Montgomery, Alabama, United States	Recruiting
Southwest Kidney Institute, PLC (SKI) - Surprise	Surprise, Arizona, United States	Recruiting
Academic Medical Research Institute (AMRI)	Los Angeles, California, United States	Recruiting
Valiance Clinical Research - Internal Medicine	Tarzana, California, United States	Recruiting
Western Nephrology & Metabolic Bone Disease PC	Arvada, Colorado, United States	Recruiting
Bioresearch Partner	Miami, Florida, United States	Recruiting
CTR Oakwater, LLC	Orlando, Florida, United States	Recruiting
Clinical Site Partners, LLC - Orlando	Winter Park, Florida, United States	Recruiting
DaVita Clinical Research Columbus	Columbus, Georgia, United States	Recruiting
Georgia Nephrology	Lawrenceville, Georgia, United States	Recruiting
CARE Institute-Boise Kidney	Boise, Idaho, United States	Recruiting
NANI Research	Hinsdale, Illinois, United States	Recruiting

+ 96 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07204275